Latest / Stock Movers / Alphabet Surges, Quantum Computing Rises, Johnson & Johnson Gains on News of Halda Deal
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio News.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 3: Let's take a look at some of the stocks on
- 0:18Speaker 3: the move today on Paul Suingiy alongside Scarletfu and we're
- 0:20Speaker 3: joined by Bloomberg's Touchanna Darya Touchan. What are you looking
- 0:23Speaker 3: at today?
- 0:24Speaker 4: Good morning, Good morning, looking at Alphabet shares. Your taker
- 0:27Speaker 4: is Google up about five percent. This is something that
- 0:30Speaker 4: came late Friday, so it might have been overlooked, but
- 0:33Speaker 4: Warren Buffett Berkshire Hathaway acquired seventeen point nine million shares
- 0:39Speaker 4: in the company. That's worth about a five billion dollar
- 0:42Speaker 4: worth of stockwell trimming shares of Bank of America and Apple.
- 0:46Speaker 4: And this comes as the company has been a net
- 0:48Speaker 4: seller of equities over the quarter, offloading about six billion.
- 0:52Speaker 4: And this is why I caught my attention. We're here
- 0:54Speaker 4: at the time when valuation concerns are so high, we're
- 0:57Speaker 4: talking about the AI bubble potentially bursting, and here's one
- 1:01Speaker 4: of the biggest value oriented investors stepping in, still seeing
- 1:05Speaker 4: value in some of the Magnificent seven names and This
- 1:09Speaker 4: just shows you that perhaps some of those bubbles concerns
- 1:12Speaker 4: are better reflected and some of the more speculative places
- 1:15Speaker 4: rather than big tech valuations, which have actually retreated over
- 1:19Speaker 4: the past five years if you look at conventional measures
- 1:22Speaker 4: like the Yeah.
- 1:24Speaker 1: Those thirteen AT filings are always fascinating, but they are
- 1:26Speaker 1: just a snapshot of a moment in time, and he
- 1:28Speaker 1: might have changed his position as well.
- 1:31Speaker 3: Coincident with him going dark stepping back, we're now seing
- 1:35Speaker 3: virtuire Hathway by big tech.
- 1:37Speaker 1: Yeah.
- 1:37Speaker 3: I never saw that before.
- 1:38Speaker 1: Remember, he only invested in things he understood, so maybe
- 1:41Speaker 1: he's now understanding.
- 1:43Speaker 3: My takeaway is he really is out of the equation.
- 1:46Speaker 4: Oh I see, I see.
- 1:47Speaker 3: Now the new managers are asserting themselves in buying tech. Gotcha, gotcha,
- 1:50Speaker 3: that's my take.
- 1:51Speaker 4: And still finding value at this priceis which is key.
- 1:54Speaker 1: That is fascinating.
- 1:55Speaker 4: I'll transition into my next name, which is Quantum Computing.
- 1:58Speaker 4: Your taker is q e b T. It's up about
- 2:01Speaker 4: twelve percent the company reported here income I will highlight
- 2:06Speaker 4: versus a loss in the quarter last year ago, revenues
- 2:09Speaker 4: rows more than two hundred percent here, and they've also
- 2:12Speaker 4: built a solid liquid position between cash and a recent
- 2:16Speaker 4: stock offering. And this caught my attention because this is
- 2:20Speaker 4: part of the speculative basket that I just referred to
- 2:23Speaker 4: on AI stock that have just you know, surged this
- 2:26Speaker 4: year on high momentum place and high hopes on AI
- 2:31Speaker 4: and then this stock went to fall and it's actually
- 2:34Speaker 4: down about thirty percent year to date. And this is
- 2:38Speaker 4: where fundamentals come in and you know, putting a floor
- 2:41Speaker 4: under this name. So it is reassuring to see that
- 2:44Speaker 4: fundamentals are just to find some of those equity moves,
- 2:48Speaker 4: although obviously not the extent of the moves that we
- 2:52Speaker 4: have seen earlier this year.
- 2:53Speaker 1: All right, let's move away from tech and the innovation
- 2:57Speaker 1: that's taking place in that sector and towards Johnson and Johnson.
- 3:01Speaker 4: And Johnson shares are hired by about one point four
- 3:04Speaker 4: percent your tickers J and J. The company has agreed
- 3:07Speaker 4: to buy the cancer treatment biotech how That Therapeutics for
- 3:10Speaker 4: about three billion dollars. This is part of a strategy
- 3:13Speaker 4: to cope with eroading sales for its major crisis drug, Stellara,
- 3:17Speaker 4: which is now facing competition after key patents expire. Obviously,
- 3:22Speaker 4: this is a big problem for all these pharma companies. Always,
- 3:26Speaker 4: when your patents expire, you see competition. You need to
- 3:28Speaker 4: look for the next big thing. This transaction is the
- 3:31Speaker 4: latest in a spate of deals in the pharma industry
- 3:33Speaker 4: as drug companies look to refuel their pipelines. We saw
- 3:36Speaker 4: Ffizer beating Nova Noordis in a bidding war for an
- 3:40Speaker 4: obesity biotech company, and Mark buying flu treatment company Cidara Therapeutics.
- 3:45Speaker 4: So this deal is just the latest in the latest
- 3:49Speaker 4: m and A wave amongst the pharma.
- 3:52Speaker 2: The Stock Movers report from Bloomberg Radio. Check back with
- 3:56Speaker 2: us throughout the day for the latest roundup of companies
- 3:59Speaker 2: making news on Wall Street and for the latest market
- 4:02Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:07Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 4:10Speaker 2: the Bloomberg Business app.